Adalimumab in childhood inflammatory Bowel disease

被引：0
|
作者：
Noc, J. D. [1 ]
Pfefferkorn, M. D. [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
PEDIATRIC RESEARCH | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
37
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [1] Short-term Response to Adalimumab in Childhood Inflammatory Bowel Disease
    Noe, Joshua D.
    Pfefferkorn, Marian
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : 1683 - 1687
  • [2] Adalimumab for the treatment of inflammatory bowel disease
    Wasan, Sharmeel K.
    Kane, Sunanda V.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (06) : 679 - 684
  • [3] Adalimumab in Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [4] Adalimumab biosimilar in inflammatory bowel disease
    Fiorino, Gionata
    Allocca, Mariangela
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 775 - 776
  • [5] Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
    Anderson, Emilia
    Waller, Karen
    Tamilarasan, Aravind Gokul
    Lin, Huiyu
    Paramsothy, Sudarshan
    Leong, Rupert W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 819 - 825
  • [6] Extrapolation and Interchangeability of Infliximab and Adalimumab in Inflammatory Bowel Disease
    Shannon Chang
    Stephen Hanauer
    Current Treatment Options in Gastroenterology, 2017, 15 (1) : 53 - 70
  • [7] Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
    Argollo, Marjorie
    Fiorino, Gionata
    Gilardi, Daniela
    Furfaro, Federica
    Roda, Giulia
    Loy, Laura
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) : 7 - 12
  • [8] Adalimumab for Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
    Carinanos, Irune
    Barreiro-De Acosta, Manuel
    Domenech, Eugeni
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (12) : E153 - E154
  • [9] Drug survival of infliximab and adalimumab in inflammatory bowel disease
    Erfan Asadipour
    Mona Kargar
    International Journal of Clinical Pharmacy, 2020, 42 : 1521 - 1523
  • [10] Drug survival of infliximab and adalimumab in inflammatory bowel disease
    Asadipour, Erfan
    Kargar, Mona
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (06) : 1521 - 1523
12345